Atria Investments, Inc

Position in ARGX — Argenx SE

CIK 1535865 Charlotte, NC

Position in ARGX

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$1,461,230

-$602,461 QoQ

Shares Held

2,001

-18.5% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Atria Investments, Inc holds $45,793,567 across 38 Biotechnology names. ARGX ranks #6 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	27,342	$12,209,296
2	REGN	Regeneron Pharmaceuticals, Inc.	11,461	$8,855,227
3	INSM	INSMED Inc	21,845	$3,572,094
4	ALNY	Alnylam Pharmaceuticals, Inc.	9,874	$3,267,010
5	ROIV	Roivant Sciences Ltd.	64,082	$1,775,071
6	ARGX	Argenx SE This page	2,001	$1,461,230
7	GMAB	Genmab A/S	45,416	$1,218,511
8	HALO	Halozyme Therapeutics, Inc.	17,877	$1,155,390

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,461,230	2,001	-18.5%	Shares	Sole	2026-05-05
2025-12-31	$2,063,691	2,454	-11.0%	Shares	Sole	2026-02-05
2025-09-30	$2,034,190	2,758	+1.8%	Shares	Sole	2025-11-06
2025-06-30	$1,492,703	2,708	+3.4%	Shares	Sole	2025-08-04
2025-03-31	$1,549,502	2,618	+0.5%	Shares	Sole	2025-05-06
2024-12-31	$1,602,690	2,606	-1.6%	Shares	Sole	2025-02-06
2024-09-30	$1,435,969	2,649	-1.0%	Shares	Sole	2024-11-01
2024-06-30	$1,150,787	2,676	-12.5%	Shares	Sole	2024-08-13
2024-03-31	$1,204,783	3,060	-12.5%	Shares	Sole	2024-05-21
2023-12-31	$1,331,124	3,499	+11.6%	Shares	Sole	2024-02-14
2023-09-30	$1,540,768	3,134	+18.1%	Shares	Sole	2023-11-07
2023-06-30	$1,033,953	2,653	-33.9%	Shares	Sole	2023-08-04
2020-03-31	$529,027	4,016	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.